Under construction – not a live service
Sign in
Taking people in NorwayNo phase

Comparing CT and MRI scans to stage newly diagnosed bladder cancer

Compares CT and MRI scans for judging how far bladder cancer has spread.

Plain-language title generated from the registry record
Registry title: Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging

Key facts

Where
Oslo, NorwaySee the site

Where in Norway

  • Oslo University HospitalOslo, NorwayTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Oslo University Hospital
Trial code
NCT07602010
Record updated
22 May 2026
Original description
This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the reference standard.Read full original descriptionShow less

Prospective Diagnostic Accuracy Study Comparing CT and MRI (VI-RADS) for Local Staging of Newly Diagnosed Bladder Cancer

This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the reference standard.

Inclusion: Age ≥ 18 years; Newly diagnosed bladder cancer on cystoscopy; Planned TURBT or cystectomy within 6 weeks; Eligible for both CT and MRI within 6 weeks; Written informed consent provided.

Exclusion: Prior treatment for bladder cancer; Non-malignant bladder lesions; Contraindications to MRI or iodinated contrast media; Pregnancy; Tumors located in bladder diverticula.

ClinicalTrials.gov NCT07602010